Nanoscope Therapeutics

About:

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.

Website: http://www.nanostherapeutics.com/

Top Investors: National Institutes of Health

Description:

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.

Total Funding Amount:

$3.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bedford, Texas, United States

Founded Date:

2017-01-01

Founders:

Samarendra Mohanty, Sulagna Bhattacharya

Number of Employees:

11-50

Last Funding Date:

2021-09-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai